FibroBiologics, Charles River Laboratories Sign Letter Of Intent Allowing For Transfer, Testing And Validation Of Technology
FibroBiologics, Charles River Laboratories Sign Letter Of Intent Allowing For Transfer, Testing And Validation Of Technology
This agreement comes ahead of entering into an anticipated master services agreement for the development and manufacture of FibroBiologics' master cell bank, working cell bank, and fibroblast-based spheroids to be utilized in clinical trials.
该协议是在达成预期的主服务协议之前达成的，该协议旨在开发和制造Fibrobiologics的主细胞库、工作细胞库和基于成纤维细胞的球体，用于临床试验。
To help advance FibroBiologics' fibroblast-based therapies into the clinic, Charles River will conduct feasibility studies on FibroBiologics' cell manufacturing processes within its facility. Additionally, contingent upon entering into a master services agreement, Charles River would serve as the contract development and manufacturing organization (CDMO) responsible for producing drug products for certain FibroBiologics' clinical trials.
为了帮助Fibrobiologics的基于成纤维细胞的疗法进入临床，查尔斯·里弗将在其设施内对Fibrobiologics的细胞制造过程进行可行性研究。此外，视签订主服务协议而定，查尔斯·里弗将担任合同开发和制造组织（CDMO），负责为某些Fibrobiologics的临床试验生产药品。